| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 178 | 198 | 193 | 203 | 205 | 225 | 225 | 210 | 146 | 291 | 279 | 294 | 346 | 308 | 296 | 312 | 283 | 305 | 292 | 284 | 280 | 310 | 293 | 334 | 316 | 353 | 325 | 352 | 394 | 430 | 415 | 433 | 455 |
| Expenses | 132 | 146 | 142 | 145 | 156 | 161 | 159 | 173 | 131 | 198 | 188 | 195 | 224 | 212 | 218 | 231 | 211 | 221 | 215 | 212 | 214 | 234 | 226 | 251 | 235 | 260 | 251 | 283 | 296 | 321 | 320 | 317 | 339 |
| EBITDA | 46 | 53 | 51 | 58 | 49 | 64 | 66 | 37 | 15 | 94 | 90 | 99 | 122 | 96 | 78 | 81 | 72 | 83 | 77 | 72 | 66 | 76 | 67 | 83 | 81 | 93 | 75 | 69 | 97 | 109 | 95 | 116 | 116 |
| Operating Profit % | 25 % | 25 % | 26 % | 28 % | 24 % | 28 % | 29 % | 16 % | 8 % | 32 % | 32 % | 33 % | 31 % | 30 % | 26 % | 24 % | 24 % | 26 % | 25 % | 25 % | 23 % | 24 % | 22 % | 24 % | 25 % | 26 % | 22 % | 18 % | 23 % | 25 % | 21 % | 25 % | 25 % |
| Depreciation | 5 | 5 | 5 | 5 | 8 | 9 | 11 | 11 | 10 | 11 | 11 | 14 | 13 | 15 | 17 | 18 | 21 | 22 | 23 | 23 | 21 | 22 | 25 | 26 | 26 | 27 | 28 | 29 | 31 | 32 | 32 | 39 | 32 |
| Interest | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 6 | 3 | 5 | 6 | 8 | 7 | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 8 | 6 |
| Profit Before Tax | 42 | 48 | 46 | 52 | 39 | 53 | 53 | 23 | 4 | 81 | 78 | 82 | 103 | 78 | 56 | 57 | 43 | 55 | 48 | 42 | 39 | 48 | 37 | 51 | 51 | 61 | 42 | 36 | 61 | 71 | 57 | 70 | 78 |
| Tax | 14 | 18 | 14 | 17 | 12 | 10 | 11 | 8 | 1 | 21 | 19 | 20 | 28 | 19 | 15 | 16 | 9 | 14 | 12 | 8 | 10 | 13 | 10 | 14 | 13 | 15 | 11 | 7 | 16 | 18 | 15 | 19 | 21 |
| Net Profit | 27 | 30 | 31 | 35 | 27 | 43 | 42 | 16 | 3 | 61 | 59 | 61 | 75 | 58 | 41 | 40 | 34 | 41 | 36 | 34 | 29 | 36 | 27 | 37 | 38 | 47 | 32 | 29 | 45 | 53 | 42 | 51 | 57 |
| EPS in ₹ | 4.83 | 6.14 | 6.26 | 6.87 | 5.34 | 8.57 | 8.38 | 3.09 | 0.57 | 11.88 | 11.50 | 12.05 | 14.65 | 11.39 | 8.02 | 7.81 | 6.53 | 7.88 | 6.99 | 6.51 | 5.62 | 6.92 | 5.30 | 7.11 | 7.41 | 9.08 | 6.12 | 5.69 | 8.70 | 10.17 | 7.99 | 2.46 | 2.73 |
Metropolis Healthcare
Metropolis Healthcare
555.00
+3.05
(0.55%)
Market Cap
11,506.69 Cr
PE Ratio
56.42
Volume
2,41,847.00
Day High - Low
565.50 - 544.40
52W High-Low
609.05 - 412.25
There are new updates from the company23 hrs ago
View
Key Fundamentals
Market Cap
11,506.69 Cr
EPS
9.19
PE Ratio
56.42
PB Ratio
7.62
Book Value
72.44
EBITDA
426.40
Dividend Yield
0.91 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
12.54
Debt to Equity
0.15
Analyst Rating and Forecast
- By Refinitiv from18 analysts
Actual
Company News
View All News
Metropolis Healthcare Ltd held its 26th AGM on August 18, 2026, via video conference. Shareholders approved the adoption of FY26 financials and a total dividend of ₹5 per share. The meeting also ratified auditor appointments and director re-appointments.
Metropolis Healthcare reported a 17% YoY revenue rise to ₹450.2 crore and 26% PAT growth in Q1FY27, driven by volume expansion and margin improvement.
Metropolis Healthcare reports consolidated net profit of ₹568.83 million for Q1FY26, a 25.7% YoY increase. Revenue from operations grew 16.6% to ₹4,502.15 million.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,887.20 | #1 31,636.60 | 58.38 | #1 2,864.20 | 12.11 | #1 510 | 27.24 | 56.60 | |
1,490.00 | 15,331.61 | 82.15 | 814.20 | 16.36 | 182 | 37.56 | 63.86 | |
555.00 | #3 11,506.69 | #6 56.42 | #2 1,671.40 | #4 24.15 | #2 191 | #7 25.61 | 46.22 | |
582.50 | 9,271.38 | 55.09 | 846.00 | 20.48 | 163 | 33.94 | 48.31 | |
691.00 | 6,933.54 | 82.56 | 1,023.40 | 32.93 | 77 | 35.02 | 52.32 | |
536.00 | 1,738.71 | 18.06 | 772.77 | 4.05 | 106 | -19.51 | 42.85 | |
308.50 | 1,606.69 | 47.17 | 310.41 | 21.30 | 34 | 40.22 | 71.09 | |
560.65 | 1,095.68 | #1 14.20 | 498.18 | #1 237.06 | 69 | #1 45.92 | - | |
313.70 | 997.90 | -35.16 | 1,319.27 | 12.68 | -3 | -92.48 | 55.51 | |
1,143.80 | 981.69 | 17.44 | 141.92 | 27.17 | 61 | -28.57 | 37.12 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
24.15 %
Net Income Growth
31.41 %
Cash Flow Change
33.47 %
ROE
15.05 %
ROCE
18.18 %
EBITDA Margin (Avg.)
7.96 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 530 | 553 | 752 | 1,004 | 1,530 | 1,502 | 1,555 | 1,867 | 2,138 |
| Fixed Assets | 207 | 213 | 296 | 343 | 1,059 | 1,121 | 1,177 | 1,447 | 1,601 |
| Current Assets | 300 | 305 | 397 | 609 | 393 | 303 | 316 | 346 | 469 |
| Capital Work in Progress | 0 | 6 | 3 | 0 | 6 | 20 | 0 | 0 | 0 |
| Investments | 102 | 33 | 14 | 10 | 16 | 15 | 55 | 71 | 142 |
| Other Assets | 221 | 301 | 439 | 651 | 450 | 347 | 323 | 349 | 395 |
| Total Equity & Liabilities | 530 | 553 | 752 | 1,004 | 1,530 | 1,502 | 1,555 | 1,867 | 2,138 |
| Current Liabilities | 91 | 125 | 170 | 204 | 302 | 265 | 246 | 294 | 334 |
| Non Current Liabilities | 11 | 8 | 58 | 92 | 341 | 246 | 210 | 238 | 280 |
| Total Equity | 429 | 420 | 525 | 708 | 888 | 991 | 1,099 | 1,335 | 1,525 |
| Reserve & Surplus | 405 | 409 | 513 | 696 | 876 | 978 | 1,078 | 1,313 | 1,461 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 42 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 4 | 14 | -1 | 18 | 8 | 56 | 279 | -321 | 3 | -6 | -23 | 15 |
| Investing Activities | -56 | 96 | -86 | 1 | 36 | -104 | 63 | -736 | 48 | -89 | -199 | -220 |
| Operating Activities | 70 | 91 | 102 | 104 | 90 | 215 | 249 | 253 | 247 | 264 | 263 | 351 |
| Financing Activities | -10 | -174 | -17 | -87 | -118 | -55 | -33 | 163 | -292 | -181 | -87 | -115 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 50.38 % | 50.37 % | 50.33 % | 49.50 % | 49.79 % | 49.79 % | 49.76 % | 49.76 % | 49.75 % | 49.75 % | 49.74 % | 49.74 % | 49.67 % | 49.62 % | 49.43 % | 49.40 % | 48.90 % | 48.89 % | 48.89 % | 48.88 % | 48.87 % | 48.86 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 24.29 % | 0.00 % | 18.90 % | 18.25 % | 18.56 % | 16.73 % | 15.29 % | 12.83 % | 12.52 % | 11.69 % | 10.43 % | 11.03 % |
| DIIs | 15.34 % | 14.22 % | 11.77 % | 10.63 % | 15.32 % | 13.85 % | 11.88 % | 13.30 % | 13.64 % | 14.47 % | 16.86 % | 20.28 % | 24.86 % | 27.43 % | 28.02 % | 30.00 % | 30.30 % | 32.40 % | 33.10 % | 34.73 % | 35.79 % | 35.12 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.95 % | 3.98 % | 4.24 % | 6.50 % | 9.14 % | 9.26 % | 9.45 % | 9.73 % | 8.53 % | 8.15 % | 7.78 % | 6.63 % | 5.24 % | 4.07 % | 3.54 % | 3.34 % | 3.84 % | 4.16 % | 3.69 % | 3.87 % | 3.99 % | 4.06 % |
| Others | 30.33 % | 31.43 % | 33.66 % | 33.37 % | 25.75 % | 27.10 % | 28.91 % | 27.21 % | 28.08 % | 27.62 % | 1.32 % | 23.35 % | 1.33 % | 0.63 % | 0.45 % | 0.53 % | 1.68 % | 1.72 % | 1.80 % | 0.83 % | 0.92 % | 0.93 % |
| No of Share Holders | 30,679 | 33,527 | 43,552 | 64,168 | 79,895 | 86,404 | 90,090 | 91,452 | 84,269 | 89,692 | 86,249 | 79,878 | 68,283 | 58,108 | 51,852 | 48,572 | 49,293 | 50,015 | 47,846 | 46,670 | 48,488 | 50,636 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 13.26 | 8 | 8 | 8 | 8 | 4 | 0.00 | 5 |
| Dividend Yield (%) | 0.00 | 0.00 | 4.13 | 1.43 | 1.57 | 2.56 | 1.86 | 1.02 | 0.00 | 0.91 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 19 Feb 2021 |  Dividend | ₹ 8.00 /share | 17 Feb 2021 | 540.89 | 502.96 |
| 22 Feb 2022 | Dividend | ₹ 8.00 /share | 21 Feb 2022 | 614.99 | 494.03 |
| 23 Feb 2023 | Dividend | ₹ 8.00 /share | 23 Feb 2023 | 322.34 | 337.15 |
| 17 Nov 2023 | Dividend | ₹ 4.00 /share | 17 Nov 2023 | 368.06 | 401.71 |
| 21 Aug 2024 |  Annual General Meeting | NA | 21 Aug 2024 | 524.58 | 522.89 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 529.78 | 528.15 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 427.23 | 439.44 |
| 13 May 2025 | Quarterly Result Announcement | NA | 13 May 2025 | 423.70 | 428.08 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 504.75 | 513.93 |
| 13 Aug 2025 | Annual General Meeting | NA | 13 Aug 2025 | 484.70 | 523.23 |
| 04 Nov 2025 | Quarterly Result Announcement | NA | 04 Nov 2025 | 488.30 | 501.11 |
| 11 Nov 2025 | Dividend | ₹ 4.00 /share | 11 Nov 2025 | 501.11 | 484.01 |
| 04 Feb 2026 | Quarterly Result Announcement | NA | 04 Feb 2026 | 450.80 | 476.08 |
| 20 Mar 2026 |  Bonus | 3:1 | 20 Mar 2026 | 454.70 | 456.29 |
| 13 May 2026 | Quarterly Result Announcement | NA | 13 May 2026 | 506.40 | 548.10 |
| 19 May 2026 | Dividend | ₹ 1.00 /share | 19 May 2026 | 548.10 | 507.40 |
| 04 Aug 2026 | Quarterly Result Announcement | NA | 04 Aug 2026 | 577.35 | 596.35 |
| 18 Aug 2026 | Annual General Meeting | NA | 18 Aug 2026 | 567.45 | 551.85 |
Announcements
Shareholder Meeting / Postal Ballot-Outcome of AGM
23 hrs ago
23 hrs agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20116 days ago
6 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20116 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2026
Aug 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 05, 2026
Aug 05, 2026Announcement under Regulation 30 (LODR)-Investor PresentationAug 04, 2026
Aug 04, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2026
Aug 04, 2026Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026Aug 04, 2026
Aug 04, 2026Board Meeting Outcome for The Meeting Held Today (August 04 2026)Aug 04, 2026
Aug 04, 2026Grant Of Stock BenefitsAug 04, 2026
Aug 04, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 04, 2026
Aug 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2026
Jul 28, 2026Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026Jul 28, 2026
Jul 28, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2026
Jul 28, 2026Letter To Shareholders Containing Weblink Of Annual Report For The Financial Year 2025-26 And 26Th Annual General MeetingJul 27, 2026
Jul 27, 2026Business Responsibility and Sustainability Reporting (BRSR)Jul 27, 2026
Jul 27, 2026Notice Of The 26Th Annual General Meeting For The Financial Year 2025-26Jul 27, 2026
Jul 27, 2026Reg. 34 (1) Annual Report.Jul 27, 2026
Jul 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2026
Jul 24, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 09, 2026
Jul 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 06, 2026
Jul 06, 2026Business Update For Q1FY27Jul 05, 2026
Jul 05, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2026
Jun 04, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
May 28, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2026
May 14, 2026General UpdateMay 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 13, 2026
May 13, 2026Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026May 13, 2026
May 13, 2026Corporate Action-Board approves DividendMay 13, 2026
May 13, 2026Board Meeting Outcome for The Meeting Held Today (May 13 2026)May 13, 2026
May 13, 2026Grant Of Stock BenefitsMay 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 07, 2026
May 07, 2026Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31 2026 And Declaration Of 2Nd Interim Dividend If Any For The Financial Year 2025-26May 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 13, 2026
Apr 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Business Update For Q4FY26Apr 03, 2026
Apr 03, 2026Closure of Trading WindowMar 31, 2026
Mar 31, 2026Announcement under Regulation 30 (LODR)-AllotmentMar 23, 2026
Mar 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2026
Mar 12, 2026Intimation Of Record Date For The Purpose Of Issuing Bonus Equity SharesMar 10, 2026
Mar 10, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 44.69
ATR(14)
Less Volatile 18.86
STOCH(9,6)
Oversold 16.58
STOCH RSI(14)
Oversold 8.87
MACD(12,26)
Bearish -4.37
ADX(14)
Weak Trend 14.22
UO(9)
Bearish 41.79
ROC(12)
Downtrend But Slowing Down -5.24
WillR(14)
Oversold -81.69
About Metropolis Healthcare
Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical...more
Listing Date
15 Apr, 2019(7 Years, 4 Months, 4 Days)
Chairperson NameAmeera Sushil Shah
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
